| Date Filed | Type | Description |
| 08/16/2023 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $11.9101, valued at
$59.6k
Exercised 5,000 options to buy
@ $2.94, valued at
$14.7k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $10.05, valued at
$50.3k
Exercised 5,000 options to buy
@ $2.94, valued at
$14.7k
|
|
| 06/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $10.3662, valued at
$51.8k
Exercised 5,000 options to buy
@ $2.94, valued at
$14.7k
|
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/27/2023 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 215,000 options to buy
@ $7.8, valued at
$1.7M
|
|
| 01/27/2022 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $2.94, valued at
$588k
|
|
| 01/28/2021 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 22,167 options to buy
@ $5.78, valued at
$128.1k
|
|
| 10/14/2020 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $7.89, valued at
$2.2M
|
|
| 10/13/2020 |
3
| Quinlan Paul T (General Counsel) has filed a Form 3 on CymaBay Therapeutics, Inc. |
| 01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2018 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $11.69, valued at
$2.9M
Granted 50,000 options to buy
@ $11.69, valued at
$584.5k
|
|
| 12/04/2017 |
3
| Quinlan Paul T (General Counsel) has filed a Form 3 on CymaBay Therapeutics, Inc. |
| 03/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/16/2016 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on TerraVia Holdings, Inc.|
Txns:
| Sold 3,124 shares
@ $2.6016, valued at
$8.1k
|
|
| 09/15/2016 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on TerraVia Holdings, Inc.|
Txns:
| Sold 1,562 shares
@ $2.7355, valued at
$4.3k
|
|
| 03/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2016 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 1,562 shares
@ $1.6646, valued at
$2.6k
Granted 62,500 shares
@ $0
Granted 350,000 options to buy
@ $1.66, valued at
$581k
|
|
| 10/21/2013 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 6,000 shares
@ $11.47, valued at
$68.8k
|
|
| 06/21/2013 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 3,000 shares
@ $12.043, valued at
$36.1k
Exercised 3,000 options to buy
@ $2.35, valued at
$7.1k
|
|
| 05/10/2013 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 21,000 shares
@ $10, valued at
$210k
Exercised 21,000 options to buy
@ $2.35, valued at
$49.4k
|
|
| 10/12/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/20/2012 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 3,000 shares
@ $11.3907, valued at
$34.2k
Exercised 3,000 options to buy
@ $2.35, valued at
$7.1k
|
|
| 09/13/2012 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 2,000 shares
@ $11.4353, valued at
$22.9k
Sold 2,000 shares
@ $11.4353, valued at
$22.9k
Exercised 2,000 options to buy
@ $2.35, valued at
$4.7k
Exercised 2,000 options to buy
@ $2.35, valued at
$4.7k
|
|
| 08/20/2012 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 3,000 shares
@ $13.1675, valued at
$39.5k
Exercised 3,000 options to buy
@ $2.35, valued at
$7.1k
|
|
| 08/13/2012 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 2,000 shares
@ $11.887, valued at
$23.8k
Exercised 2,000 options to buy
@ $2.35, valued at
$4.7k
|
|
| 07/20/2012 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 3,000 shares
@ $13.5051, valued at
$40.5k
Exercised 3,000 options to buy
@ $2.35, valued at
$7.1k
|
|
| 07/12/2012 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 2,000 shares
@ $11.421, valued at
$22.8k
Exercised 2,000 options to buy
@ $2.35, valued at
$4.7k
|
|
| 06/13/2012 |
4
| Quinlan Paul T (General Counsel) has filed a Form 4 on SOLAZYME INC|
Txns:
| Sold 2,000 shares
@ $12.2255, valued at
$24.5k
Exercised 2,000 options to buy
@ $2.35, valued at
$4.7k
|
|
|